Literature DB >> 33277946

Seeking to Understand the Conditions Under Which Exposure-Based Writing Therapy for Posttraumatic Stress Disorder is an Effective Approach: A Commentary on Dawson et al. (2020).

Johanna Thompson-Hollands1, Denise M Sloan1, Brian P Marx1.   

Abstract

Exposure-based writing interventions for posttraumatic stress disorder (PTSD) have shown promise when compared with waitlist conditions, placebo writing control conditions, and evidence-based, trauma-focused treatments. Recently, Dawson et al. (2020) conducted a systematic review and meta-analysis to examine existing published randomized controlled trials investigating exposure-based writing interventions. The findings were encouraging; however, the studies included in the meta-analysis had a high degree of methodological heterogeneity. Our own work examining exposure-based writing as an intervention for PTSD has demonstrated that methodological differences in the structure of exposure-based writing can have a meaningful impact on treatment outcome. Accordingly, we urge caution in interpreting the meta-analysis findings reported by Dawson and colleagues and encourage investigation into better understanding the mechanisms underlying exposure-based writing interventions to further propel this important area of work. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2020        PMID: 33277946      PMCID: PMC9022620          DOI: 10.1002/jts.22633

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  13 in total

1.  Confronting a traumatic event: toward an understanding of inhibition and disease.

Authors:  J W Pennebaker; S K Beall
Journal:  J Abnorm Psychol       Date:  1986-08

2.  Further examination of the exposure model underlying the efficacy of written emotional disclosure.

Authors:  Denise M Sloan; Brian P Marx; Eva M Epstein
Journal:  J Consult Clin Psychol       Date:  2005-06

3.  Internet-based cognitive-behavioral therapy for complicated grief: a randomized controlled trial.

Authors:  Birgit Wagner; Christine Knaevelsrud; Andreas Maercker
Journal:  Death Stud       Date:  2006-06

4.  Does altering the writing instructions influence outcome associated with written disclosure?

Authors:  Denise M Sloan; Brian P Marx; Eva M Epstein; Jennifer M Lexington
Journal:  Behav Ther       Date:  2007-01-18

5.  Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors.

Authors:  Denise M Sloan; Brian P Marx; Michelle J Bovin; Brian A Feinstein; Matthew W Gallagher
Journal:  Behav Res Ther       Date:  2012-07-20

6.  A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence.

Authors:  Patricia A Resick; Tara E Galovski; Mary O'Brien Uhlmansiek; Christine D Scher; Gretchen A Clum; Yinong Young-Xu
Journal:  J Consult Clin Psychol       Date:  2008-04

Review 7.  Expanding the Reach of Effective PTSD Treatment Into Primary Care: Prolonged Exposure for Primary Care.

Authors:  Sheila A M Rauch; Jeffrey Cigrang; David Austern; Ashley Evans
Journal:  Focus (Am Psychiatr Publ)       Date:  2017-10-12

8.  A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial.

Authors:  Denise M Sloan; Brian P Marx; Daniel J Lee; Patricia A Resick
Journal:  JAMA Psychiatry       Date:  2018-03-01       Impact factor: 21.596

9.  Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial.

Authors:  Christine Knaevelsrud; Janine Brand; Alfred Lange; Jeroen Ruwaard; Birgit Wagner
Journal:  J Med Internet Res       Date:  2015-03-20       Impact factor: 5.428

10.  Internet-based treatment for PTSD reduces distress and facilitates the development of a strong therapeutic alliance: a randomized controlled clinical trial.

Authors:  Christine Knaevelsrud; Andreas Maercker
Journal:  BMC Psychiatry       Date:  2007-04-19       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.